13F-HR filed by BAKER BROS. ADVISORS LP
BAKER BROS. ADVISORS LP filed this 13F-HR for the quarter ended 2017-03-31, filed 2017-05-15, with 119 holding rows worth $12,220,691,000.
- Accession
- 0001144204-17-027430
- Filer
- CIK 1263508
- Filed
- 2017-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2017
A holdings report, 119 entries on the cover page, a total value of $12,220,691,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $12,220,691,000 with VALUE read as thousands by filing date, 13F file number 028-10519. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| INCYTE CORP COM | 45337C102 | Stock | 34,110,011 | $4,559,485,000 | thousands by filing date | |
| SEATTLE GENETICS INC | 812578102 | COM | 45,715,556 | $2,873,680,000 | thousands by filing date | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 25,819,768 | $887,684,000 | thousands by filing date | |
| ALEXION PHARMACEUTICALS INC | 015351109 | COM | 6,544,130 | $793,410,000 | thousands by filing date | |
| GENOMIC HEALTH, INC. | 37244C101 | COM | 13,770,982 | $433,648,000 | thousands by filing date | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 4,806,483 | $421,913,000 | thousands by filing date | |
| DBV TECHNOLOGIES S A | 23306J101 | ADR | 5,509,560 | $194,047,000 | thousands by filing date | |
| AQUINOX PHARMACEUTICALS INC | 03842B101 | COM | 10,934,154 | $182,491,000 | thousands by filing date | |
| BEONE MEDICINES LTD SPONSORED ADS | 07725L102 | ADR | 3,673,175 | $134,475,000 | thousands by filing date | |
| ACHAOGEN INC | 004449104 | COM | 4,582,382 | $115,613,000 | thousands by filing date | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 11,716,784 | $98,421,000 | thousands by filing date | |
| BIOMARIN PHARMACEUTICAL INC | 09061GAD3 | CNV | 22,379,000 | $95,967,000 | thousands by filing date | principal |
| ADVANCED ACCELERATOR APPLIC SPONSORED ADS | 00790T100 | ADR | 2,221,706 | $88,557,000 | thousands by filing date | |
| INVITAE CORP | 46185L103 | COM | 7,288,300 | $80,609,000 | thousands by filing date | |
| AMARIN CORP PLC | 023111206 | SPONS ADR NEW | 22,656,469 | $72,501,000 | thousands by filing date | |
| SPARK THERAPEUTICS INC | 84652J103 | COM | 1,318,341 | $70,320,000 | thousands by filing date | |
| ACORDA THERAPEUTICS INC | 00484M106 | COM | 3,301,791 | $69,338,000 | thousands by filing date | |
| BELLICUM PHARMACEUTICALS INC | 079481107 | COM | 5,032,313 | $62,099,000 | thousands by filing date | |
| CERUS CORP | 157085101 | COM | 13,053,275 | $58,087,000 | thousands by filing date | |
| EXELIXIS INC COM | 30161Q104 | Stock | 2,603,569 | $56,419,000 | thousands by filing date | |
| NOVAVAX INC | 670002AB0 | NOTE 3.750% 2/0 | 108,500,000 | $48,554,000 | thousands by filing date | principal |
| HERON THERAPEUTICS INC | 427746102 | COM | 2,783,569 | $41,754,000 | thousands by filing date | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 895,422 | $38,772,000 | thousands by filing date | |
| AVEXIS INC | 05366U100 | COM | 500,000 | $38,015,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 1,351,463 | $37,841,000 | thousands by filing date | |
| VERSARTIS INC | 92529L102 | COM | 1,660,593 | $35,454,000 | thousands by filing date | |
| BLUEBIRD BIO INC | 09609G100 | COM | 351,441 | $31,946,000 | thousands by filing date | |
| PROGENICS PHARMACEUTICALS IN | 743187106 | COM | 3,150,808 | $29,744,000 | thousands by filing date | |
| ACORDA THERAPEUTICS INC | 00484MAA4 | NOTE 1.750% 6/1 | 35,083,000 | $29,696,000 | thousands by filing date | principal |
| MERUS N V | N5749R100 | COM | 1,160,014 | $28,293,000 | thousands by filing date | |
| IDERA PHARMACEUTICALS INC | 45168K306 | COM | 10,286,483 | $25,408,000 | thousands by filing date | |
| SANGAMO THERAPEUTICS INC | 800677106 | COM | 4,530,901 | $23,561,000 | thousands by filing date | |
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 259,894 | $22,400,000 | thousands by filing date | |
| XENCOR INC | 98401F105 | COMMON STOCK | 872,072 | $20,860,000 | thousands by filing date | |
| HALOZYME THERAPEUTICS INC COM | 40637H109 | Stock | 1,391,507 | $18,034,000 | thousands by filing date | |
| NEURODERM LTD | M74231107 | ORD SHS | 571,667 | $15,178,000 | thousands by filing date | |
| INTELLIA THERAPEUTICS INC | 45826J105 | COM | 1,062,120 | $14,965,000 | thousands by filing date | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 208,328 | $14,806,000 | thousands by filing date | |
| AIMMUNE THERAPEUTICS INC. | 00900T107 | Common Stock | 673,908 | $14,644,000 | thousands by filing date | |
| ARRAY BIOPHARMA INC COM | 04269X105 | Stock | 1,585,913 | $14,178,000 | thousands by filing date | |
| DERMIRA INC | 24983L104 | COM | 415,448 | $14,171,000 | thousands by filing date | |
| BIOMARIN PHARMACEUTICAL INC | 09061GAE1 | NOTE 0.750%10/1 | 12,228,000 | $13,830,000 | thousands by filing date | principal |
| AERIE PHARMACEUTICALS INC | 00771V108 | COM | 299,356 | $13,576,000 | thousands by filing date | |
| AEGERION PHARMACEUTICALS INC | 00767EAB8 | NOTE 2.000 8/1 | 16,517,000 | $13,241,000 | thousands by filing date | principal |
| FOAMIX PHARMACEUTICALS LTD | M46135105 | SHS | 2,466,702 | $12,210,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 2,269,198 | $11,800,000 | thousands by filing date | |
| IMMUNOGEN INC | 45253H101 | COMMON STOCK | 3,015,353 | $11,669,000 | thousands by filing date | |
| LA JOLLA PHARMACEUTICAL CO | 503459604 | COM PAR $.0001 2 | 379,134 | $11,317,000 | thousands by filing date | |
| CATALYST PHARMACEUTICALS INC | 14888U101 | COM | 5,102,153 | $9,949,000 | thousands by filing date | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 609,166 | $9,899,000 | thousands by filing date | |
| ALKERMES PLC | G01767105 | SHS | 150,251 | $8,790,000 | thousands by filing date | |
| ABEONA THERAPEUTICS INC | 00289Y107 | COM | 1,684,364 | $8,422,000 | thousands by filing date | |
| RIGEL PHARMACEUTICALS INC | 766559603 | COMMON STOCK | 2,518,882 | $8,337,000 | thousands by filing date | |
| ACHILLION PHARMACEUTICALS IN | 00448Q201 | COM | 1,856,637 | $7,816,000 | thousands by filing date | |
| LIGAND PHARMACEUTICALS INC | 53220K504 | COM NEW | 73,386 | $7,767,000 | thousands by filing date | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 128,666 | $7,514,000 | thousands by filing date | |
| CONTRAFECT CORP | 212326102 | COM | 4,045,876 | $7,283,000 | thousands by filing date | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 400,000 | $7,004,000 | thousands by filing date | |
| MACROGENICS INC | 556099109 | COM | 363,676 | $6,764,000 | thousands by filing date | |
| ASSEMBLY BIOSCIENCES INC | 045396108 | COM | 250,000 | $6,373,000 | thousands by filing date | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 1,413,499 | $6,078,000 | thousands by filing date | |
| LOXO ONCOLOGY INC | 548862101 | COM | 137,735 | $5,796,000 | thousands by filing date | |
| AKARI THERAPEUTICS PLC | 00972G108 | ADR | 496,901 | $5,501,000 | thousands by filing date | |
| STEMLINE THERAPEUTICS INC | 85858C107 | COM | 633,497 | $5,416,000 | thousands by filing date | |
| IGNYTA INC | 451731103 | COM | 571,000 | $4,911,000 | thousands by filing date | |
| ALDER BIOPHARMACEUTICALS INC | 014339105 | COM | 217,328 | $4,520,000 | thousands by filing date | |
| BIOGEN INC COM | 09062X103 | Stock | 16,500 | $4,511,000 | thousands by filing date | |
| ARRAY BIOPHARMA INC | 04269XAA3 | NOTE 3.000% 6/0 | 3,000,000 | $4,258,000 | thousands by filing date | principal |
| NABRIVA THERAPEUTICS AG | 62957M104 | SPONSORED ADR | 350,000 | $4,200,000 | thousands by filing date | |
| ANAPTYSBIO INC | 032724106 | COM | 150,000 | $4,163,000 | thousands by filing date | |
| ZOGENIX INC. | 98978L204 | Common Stock | 381,939 | $4,144,000 | thousands by filing date | |
| EPIZYME INC | 29428V104 | COM | 232,481 | $3,987,000 | thousands by filing date | |
| RA PHARMACEUTICALS INC | 74933V108 | COM | 177,952 | $3,789,000 | thousands by filing date | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 50,000 | $3,389,000 | thousands by filing date | |
| SYROS PHARMACEUTICALS INC | 87184Q107 | COM | 204,465 | $3,257,000 | thousands by filing date | |
| TREVENA INC | 89532E109 | COM | 857,206 | $3,146,000 | thousands by filing date | |
| SUNESIS PHARMACEUTICALS INC | 867328700 | COM | 741,665 | $3,041,000 | thousands by filing date | |
| ADAMAS PHARMACEUTICALS INC | 00548A106 | COM | 172,630 | $3,021,000 | thousands by filing date | |
| AEVI GENOMIC MEDICINE INC | 00835P105 | COM | 1,618,089 | $3,010,000 | thousands by filing date | |
| INOTEK PHARMACEUTICALS CORP | 45780VAB8 | NOTE 5.750% 8/0 | 5,000,000 | $3,008,000 | thousands by filing date | principal |
| KARYOPHARM THERAPEUTICS INC | 48576U106 | COM | 216,990 | $2,786,000 | thousands by filing date | |
| TRILLIUM THERAPEUTICS INC COM NEW | 89620X506 | Stock | 413,697 | $2,544,000 | thousands by filing date | |
| PROTALIX BIOTHERAPEUTICS INC | 74365AAB7 | NOTE 4.500% 9/1 | 3,423,000 | $2,543,000 | thousands by filing date | principal |
| SELECTA BIOSCIENCES INC | 816212104 | COM | 175,712 | $2,516,000 | thousands by filing date | |
| JOUNCE THERAPEUTICS INC | 481116101 | COM | 100,000 | $2,199,000 | thousands by filing date | |
| DIMENSION THERAPEUTICS INC | 25433V105 | COM | 1,251,881 | $2,191,000 | thousands by filing date | |
| TONIX PHARMACEUTICALS HLDG C | 890260409 | COM | 449,500 | $2,099,000 | thousands by filing date | |
| GLYCOMIMETICS INC | 38000Q102 | COM | 381,235 | $2,070,000 | thousands by filing date | |
| NATERA INC COM | 632307104 | Stock | 228,676 | $2,028,000 | thousands by filing date | |
| SPRING BK PHARMACEUTICALS IN | 849431101 | COM | 219,298 | $1,952,000 | thousands by filing date | |
| INFINITY PHARMACEUTICALS INC | 45665G303 | COM | 580,400 | $1,875,000 | thousands by filing date | |
| INVIVO THERAPEUTICS HLDGS CO | 46186M209 | COM NEW | 400,000 | $1,620,000 | thousands by filing date | |
| MEDIWOUND LTD | M68830104 | ORD SHS | 226,000 | $1,492,000 | thousands by filing date | |
| AEGLEA BIOTHERAPEUTICS INC | 00773J103 | COM | 189,987 | $1,415,000 | thousands by filing date | |
| SERES THERAPEUTICS INC | 81750R102 | COM | 125,000 | $1,409,000 | thousands by filing date | |
| FULGENT GENETICS INC | 359664109 | COM | 125,000 | $1,365,000 | thousands by filing date | |
| MYOKARDIA INC | 62857M105 | COM | 100,000 | $1,315,000 | thousands by filing date | |
| CELLECTIS ADS | 15117K103 | COM | 50,000 | $1,200,000 | thousands by filing date | |
| JUNO THERAPEUTICS INC | 48205A109 | COM | 50,000 | $1,110,000 | thousands by filing date | |
| CORBUS PHARMACEUTICALS HLDGS | 21833P103 | COM | 130,129 | $1,074,000 | thousands by filing date | |
| IMMUNE DESIGN CORP. | 45252L103 | Common Stock | 148,937 | $1,013,000 | thousands by filing date | |
| AFFIMED N V | N01045108 | COM | 400,000 | $920,000 | thousands by filing date | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 57,762 | $890,000 | thousands by filing date | |
| ACCELERON PHARMA INC | 00434H108 | COM | 28,765 | $761,000 | thousands by filing date | |
| CHIMERIX INC COM | 16934W106 | Stock | 115,216 | $735,000 | thousands by filing date | |
| FIVE PRIME THERAPEUTICS INC. | 33830X104 | Common Stock | 19,247 | $696,000 | thousands by filing date | |
| PALATIN TECHNOLOGIES INC | 696077403 | COM PAR $ .01 | 2,050,000 | $671,000 | thousands by filing date | |
| Arbutus Biopharma Corp | 03879J100 | Common Shares, without par value | 180,582 | $587,000 | thousands by filing date | |
| RITTER PHARMACEUTICALS INC | 767836109 | COM | 400,000 | $568,000 | thousands by filing date | |
| ADAPTIMMUNE THERAPEUTICS PLC | 00653A107 | SPONDS ADR | 100,000 | $551,000 | thousands by filing date | |
| PROTEON THERAPEUTICS INC | 74371L109 | COM | 298,591 | $523,000 | thousands by filing date | |
| BIOVERATIV INC | 09075E100 | COM | 8,249 | $449,000 | thousands by filing date | |
| DYNAVAX TECHNOLOGIES CORP | 268158201 | COM NEW | 75,000 | $446,000 | thousands by filing date | |
| BIODELIVERY SCIENCES INTL IN | 09060J106 | COM | 210,021 | $399,000 | thousands by filing date | |
| CHEMOCENTRYX INC | 16383L106 | COM | 49,064 | $357,000 | thousands by filing date | |
| WINDTREE THERAPEUTICS INC | 97382D105 | COM | 254,973 | $291,000 | thousands by filing date | |
| BIOPHARMX CORP | 09072X101 | COM | 377,295 | $191,000 | thousands by filing date | |
| BIO GREEN MED SOL 6pcnt PFDCONV | 23254L207 | COMMON STOCK | 13,253 | $83,000 | thousands by filing date | |
| BIOTIME INC | 09066L162 | W EXP 10/01/201 | 20,084 | $12,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001144204-17-027430 | this filing | 2017-05-15 | acceptance time not in the bulk data set |